I've had a request from Patient Power for help from UK lung cancer patients who may be eligible to take part in a survey about their experience with their immunotherapy treatments. If you or anyone you know is eligible, please contact Laura directly at email@example.com if you or they fit the criteria described below:-
"If you’ve received immunotherapy (such as Opdivo, Keytruda or Tecentriq) for your non-small cell lung cancer within the last 12 months (or currently are on treatment) as part of routine care or by taking part in a clinical trial and would like to help other patients by sharing your story, please contact Laura by email at firstname.lastname@example.org.
We are seeking participants for an interview study consisting of two telephone calls: an informational telephone call to determine interest and eligibility (approximately 20 minutes) and an interview telephone call (approximately 1 hour). Open to residents of the UK; qualified candidates who participate in the interview telephone call will be compensated for their time.
Please note: Tarceva, Giotrif and Iressa are considered targeted therapies; NSCLC patients who have had targeted therapy but have not yet had immunotherapy will not meet inclusion criteria for this study."